Trials / Recruiting
RecruitingNCT05804786
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
Korean Multicenter Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,240 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is To evaluate the usefulness and safety of advanced guided bronchoscopy for histological diagnosis of peripheral pulmonary lesions. The Secondary objective is to establish a strategy that can most effectively use endoscopes for early diagnosis of lung cancer in a real-world care environment by identifying patient/clinical/image/procedure-related characteristics that can optimize the practicality of emerging technologies.
Detailed description
* Patients with peripheral pulmonary lesions who need histological diagnosis due to suspected lung cancer and whose lesions are judged capable of histological examination through guided bronchoscopy will be prospectively recruited. * This study is a pure non-interventional pragmatic design. In addition to biopsy for lung lesions using bronchoscopy, lung cancer staging and tests necessary for metastases and treatment for diagnosed lung cancer are performed according to existing guidelines and the judgment of medical staff. * We will analyze the clinical characteristics of guided bronchoscopy procedures used in clinical practice and the main results during the follow-up period of up to one year (diagnostic yield, sensitivity, safety, practicality, and various factors affecting usefulness).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Guided bronchoscopy | It is performed when a pulmonary lesion with a possibility of malignancy is found on chest CT and histological diagnosis and differentiation are required. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2027-07-31
- Completion
- 2027-07-31
- First posted
- 2023-04-07
- Last updated
- 2024-05-10
Locations
11 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05804786. Inclusion in this directory is not an endorsement.